SYCP2 and breast carcinoma: DNA methylation, keratinocyte differentiation, steroid hormone biosynthesis, and immune infiltration are likely to be the vital pathway regulated by SYCP2. Accordingly, this study may provide a reference for the development of prognostic indicators and novel therapeutic targets in patients suffering from breast carcinoma.